Skip to main content
. 2020 Jun 10;150(9):2278–2286. doi: 10.1093/jn/nxaa156

FIGURE 2.

FIGURE 2

Study flow and outcome measurements during 8 wk of the dosing period and 4 wk of the posttreatment observation period. Scoring on the Japan Low Back Pain Evaluation Questionnaire (JLEQ), Japanese Knee Osteoarthritis Measure (JKOM), Japanese Orthopedic Association (JOA), and Brief Pain Inventory (BPI), quality-of-life (QOL) assessment by EuroQOL 5 Dimensions 5-level (EQ-5D-5L), and medical interviews were conducted at baseline and weeks 4 and 8 (dosing period), and week 12 (posttreatment period).